Literature DB >> 21233251

Role of histone deacetylases in vascular cell homeostasis and arteriosclerosis.

Boda Zhou1, Andriana Margariti, Lingfang Zeng, Qingbo Xu.   

Abstract

Histone deacetylases (HDACs) are a family of enzymes that remove acetyl groups from lysine residues of histone proteins, a modification that results in epigenetic modulation of gene expression. Although originally shown to be involved in cancer and neurological disease, HDACs are also found to play crucial roles in arteriosclerosis. This review summarizes the effects of HDACs and HDAC inhibitors on proliferation, migration, and apoptosis of endothelial and smooth muscle cells. In addition, an updated discussion of HDACs' recently discovered effects on stem cell differentiation and atherosclerosis is provided. Overall, HDACs appear to be promising therapeutic targets for the treatment of arteriosclerosis and other cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21233251     DOI: 10.1093/cvr/cvr003

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  35 in total

1.  Role of histone deacetylases in transcription factor regulation and cell cycle modulation in endothelial cells in response to disturbed flow.

Authors:  Ding-Yu Lee; Chih-I Lee; Ting-Er Lin; Seh Hong Lim; Jing Zhou; Ying-Chih Tseng; Shu Chien; Jeng-Jiann Chiu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-23       Impact factor: 11.205

2.  Review focus on epigenetics and the histone code in vascular biology.

Authors:  Seppo Ylä-Herttuala; Christopher K Glass
Journal:  Cardiovasc Res       Date:  2011-06-01       Impact factor: 10.787

Review 3.  Current trends in selection of conduits for coronary artery bypass grafting.

Authors:  Thierry Carrel; Bernhard Winkler
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-08-09

Review 4.  Histone Deacetylases and Cardiometabolic Diseases.

Authors:  Kan Hui Yiew; Tapan K Chatterjee; David Y Hui; Neal L Weintraub
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-07-16       Impact factor: 8.311

Review 5.  Epigenetic regulation of vascular smooth muscle cell function in atherosclerosis.

Authors:  Hannes M Findeisen; Florian K Kahles; Dennis Bruemmer
Journal:  Curr Atheroscler Rep       Date:  2013-05       Impact factor: 5.113

6.  Detrimental effect of class-selective histone deacetylase inhibitors during tissue regeneration following hindlimb ischemia.

Authors:  Francesco Spallotta; Silvia Tardivo; Simona Nanni; Jessica D Rosati; Stefania Straino; Antonello Mai; Matteo Vecellio; Sergio Valente; Maurizio C Capogrossi; Antonella Farsetti; Julie Martone; Irene Bozzoni; Alfredo Pontecorvi; Carlo Gaetano; Claudia Colussi
Journal:  J Biol Chem       Date:  2013-07-07       Impact factor: 5.157

7.  Improving data quality and preserving HCD-generated reporter ions with EThcD for isobaric tag-based quantitative proteomics and proteome-wide PTM studies.

Authors:  Qing Yu; Xudong Shi; Yu Feng; K Craig Kent; Lingjun Li
Journal:  Anal Chim Acta       Date:  2017-03-16       Impact factor: 6.558

8.  Histone deacetylase inhibitors prevent pulmonary endothelial hyperpermeability and acute lung injury by regulating heat shock protein 90 function.

Authors:  Atul D Joshi; Nektarios Barabutis; Charalampos Birmpas; Christiana Dimitropoulou; Gagan Thangjam; Mary Cherian-Shaw; John Dennison; John D Catravas
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-10-23       Impact factor: 5.464

9.  Metabolic Diseases Downregulate the Majority of Histone Modification Enzymes, Making a Few Upregulated Enzymes Novel Therapeutic Targets--"Sand Out and Gold Stays".

Authors:  Ying Shao; Valeria Chernaya; Candice Johnson; William Y Yang; Ramon Cueto; Xiaojin Sha; Yi Zhang; Xuebin Qin; Jianxin Sun; Eric T Choi; Hong Wang; Xiao-feng Yang
Journal:  J Cardiovasc Transl Res       Date:  2016-01-08       Impact factor: 4.132

10.  Histone deacetylase 9 represses cholesterol efflux and alternatively activated macrophages in atherosclerosis development.

Authors:  Qiang Cao; Shunxing Rong; Joyce J Repa; Richard St Clair; John S Parks; Nilamadhab Mishra
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-07-17       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.